Report workspace

Add to folder
NCT02406053COMPLETEDanonymous

Evaluation of Oxidative Damage and Antioxidant Mechanisms in COPD, Lung Cancer, and Obstructive Sleep Apnea Syndrome

Sponsor

Source record

Yuzuncu Yil University

Phase

Source record

Not classified

Modality

AI-normalized

gene therapy

Target

AI-normalized

oxidative and antioxidant biomarkers

Indication / condition

AI-normalized

Respiratory Diseases

Intervention

Source record

oxidative and antioxidant biomarkers

Source & freshness

Source record

NCT ID

NCT02406053

Original source

ClinicalTrials.gov

Source last updated

Apr 02, 2015

Ingested at

Jun 19, 2026

Internal sync

Jun 19, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02406053

Title

Evaluation of Oxidative Damage and Antioxidant Mechanisms in COPD, Lung Cancer, and Obstructive Sleep Apnea Syndrome

Sponsor

Yuzuncu Yil University

Status

COMPLETED

Phase

Detailed source ingestion pending

Condition raw

Respiratory Diseases

Condition normalized

Respiratory Diseases

Modality raw

gene therapy

Modality normalized

gene therapy

Target raw

oxidative and antioxidant biomarkers

Target normalized

oxidative and antioxidant biomarkers

Interventions

oxidative and antioxidant biomarkers

Public preview

Source record

The environmental pollutants and endogenous reactive oxygen metabolites from inflammatory cells exert substantial pathological effects on the lung cells \[1\]. Oxidative stress (OS) is a major factor that plays a significant role in lung cancer (LC) \[2\], chronic obstructive pulmonary disease (COPD) \[3\] and obstructive sleep apnea syndrome (OSAS) \[4, 5\]. The current evidence suggests that OS takes part in the mechanisms involved in initiation, promotion and progression of respiratory diseases. The major exposures that cause OS can be summarized as smoking, and ambient air pollution that contains particulate matter smaller than aerodynamic diameter of 2.5 µm \[6-8\]. Epidemiological and clinical studies showed that the overall outcome of pulmonary OS is increased mortality due to increased incidence of respiratory diseases \[9\].

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.